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013.01.00Abstract Aim of the work: To determine the prevalence and disease characteristics of Systemic
Sclerosis among Egyptian patients presented to Rheumatology departments in Cairo University
& Bani Swief University.
Patients & methods: This is a retrospective study that included 75 patients with systemic sclerosis
diagnosed according to the American college of rheumatology criteria. Their ages ranged between
17 and 70 years, all patients data were collected by medical records review.
Results: Out of the studied 75 patients, 14 (18.7%) were males and 61 (81.3%) were females with
a ratio of 1:4.3. Fourteen patients (18.7%) had diffuse cutaneous systemic sclerosis and 61/75
(81.3%) had limited cutaneous systemic sclerosis. The commonest initial presenting manifestation
in all patients was Raynaud’s phenomenon in 58/75 patients (77.3%), followed by arthritis in 9/
75 patients (12%) & skin tightness in 7/75 patients (9.3%). Interstitial lung disease was signiﬁcantly
more frequent within the diffuse compared to the limited subtype (78.6%, 47.5%, respectively
P= 0.042). Secondary pulmonary hypertension was signiﬁcantly more common among the
patients with dcSSc compared to the limited subtype (35.7%, 6.6%, respectively P= 0.009). No
signiﬁcant difference was observed between males and females in the disease pattern.7411241.
(H. E. A. Darweesh).
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146 G. Abdel Moneim et al.Conclusion: Limited cutaneous systemic sclerosis is more common than diffuse ‘subtype’. Ray-
naud’s phenomenon is the commonest initial presentation. Diffuse subtype is more commonly asso-
ciated with interstitial lung disease, secondary pulmonary hypertension and proteinuria than the
limited subtype. Gender does not affect the frequency of organ involvement signiﬁcantly.
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Systemic sclerosis (SSc) is a chronic multisystem autoimmune
disease that is highly heterogeneous and has multiple overlap-
ping and poorly deﬁned clinical subsets [1].
The usual hallmarks of (SSc) are autoimmunity, inﬂamma-
tion, widespread small-vessel vasculopathy affecting multiple
vascular beds, and progressive interstitial and vascular ﬁbrosis
in the skin as well as in internal organs, with the lungs, heart,
gastrointestinal tract, and kidneys being the main targets [2].
The relative rarity and clinical heterogeneity of (SSc) have
made formal epidemiological studies difﬁcult. The estimated
prevalence from population based studies is between 1 and 2
per 10,000 population, with a higher estimated prevalence in
North America. There appear to be two peaks of disease onset
– the early 30s and mid 50s – and, in common with most other
autoimmune diseases [3].The disease has a female predilection
with female: male ratio of 3:1 [4].
SSc is divided into two main subsets, according to the ex-
tent of skin affection in addition to the speciﬁc autoantibodies.
These subsets are the limited cutaneous systemic sclerosis
(lcSSc) and the diffuse cutaneous systemic sclerosis (dcSSc) [5].
The clinical expression, severity and progression are rather
heterogeneous; the disease may progress very slowly with no or
mild visceral injury, whereas sometimes it dramatically evolves
with early severe organ damage [6].
The aim of this work is to determine the prevalence and dis-
ease characteristics of systemic sclerosis among Egyptian pa-
tients presented to Rheumatology departments in Cairo
University & Bani Swief University.
2. Patients & methods
A retrospective study was done on seventy ﬁve patients with
systemic sclerosis, all fulﬁlling the criteria of the American
College of Rheumatology (ACR) for classiﬁcation of sclero-
derma [7]. They were recruited from the Rheumatology and
Rehabilitation departments, Cairo and Bani Swief Universi-
ties. The patients data were collected from the medical records
& reported in formulated sheets to identify the disease charac-
teristics and pattern of internal organ involvement; pulmonary
ﬁbrosis, pulmonary hypertension & proteinuria.
2.1. Inclusion criteria
Patients were classiﬁed to have dcSSc or lcSSc according to the
scleroderma classiﬁcation in 1988 [4].
Statistical analysis: The data were coded and entered using
the statistical package SPSS version 15. The data were summa-
rized using descriptive statistics: mean, standard deviation,
minimal and maximum values for quantitative variables and
number and percentage for qualitative variables, statistical dif-ferences between groups were tested using Chi Square test for
qualitative variables & independent sample t test for quantita-
tive normally distributed variables. Spearman’s correlation
was used for non parameteric variables. P-values less than
0.05 were considered statistically signiﬁcant.
3. Results
Out of the studied 75 patients, 14 (18.7%) were males and 61
(81.3%) were females with a ratio of 1:4.3. Their ages ranged
from 17 to 70 years with a mean age of 36.17 ± 13.9 years.
Their disease duration ranged from 4 months to 20 years with
a mean duration of 6.35 ± 4.7 years. Their age at disease onset
ranged from 9 to 67 years with a mean of 29.83 ± 13.1. Four-
teen patients out of 75 (18.7%) had dcSSc and 61/75 (81.3%)
had lcSSc with a ratio of 1:4.3.
We found that within the limited subtype, 11/61 (18%) were
males and 50/61 (82%) were females with a ratio of 1:4.6.
While in the diffuse subtype, 3/14 (21.4%) were males and
11/14 (78.6%) were females with a ratio of 1:3.7. Females were
found to be signiﬁcantly more commonly affected as compared
to males within both disease subsets (P= 0.001 in lcSS and
0.007 in dcSSc).
On comparison between the limited & diffuse subtypes as re-
gards their demographic data, no signiﬁcant difference was ob-
served between both groups, also the comparison betweenmales
& females within each subtype showed no signiﬁcant difference
apart from the age, where the females within the diffuse subtype
were signiﬁcantly older than the males (p= 0.034).
Regarding the ﬁrst presenting manifestation in all patients
included in the study, the commonest was Raynaud’s phenom-
enon in 58/75 patients (77.3%), followed by arthritis in 9/75 pa-
tients (12%), skin tightness in 7/75 patients (9.3%) and muscle
weakness in 1/75 patient (1.3%).
Comparing the lcSS & dcSS subtypes as regards their age,
age of onset, disease duration & initial presenting manifesta-
tions, a highly signiﬁcant difference was found in the incidence
of skin tightness between both groups, being more common in
the diffuse than the limited subtype (p= 0.001). But no signif-
icant difference could be found in other manifestations (Tables
1 and 2).
Raynaud’s phenomenon was the ﬁrst presenting manifesta-
tion in 11/14 (78.6%) male patients being the commonest ﬁrst
disease manifestation in males, followed by arthritis in 2/14 pa-
tients (14.3%) then skin tightness in 1/14 patient (7.1%). The
same order occurred in female patients where Raynaud’s phe-
nomenon was the ﬁrst disease manifestation in 47/61 patients
(77%), arthritis in 7/61 patients (11.5%) and skin tightness
in 6/61 patients (9.8%). One female had myositis as her ﬁrst
disease manifestation with a percent of (1.6%). No statistical
signiﬁcant difference was found between males and females
regarding the ﬁrst presenting manifestation.
Table 3 Comparison between lcSS and dcSS subtypes as regards the frequency of organ involvement.
Total (n= 75) lcSS (%) (n= 61) dcSS (%) (n= 14) P value Sig.
Skin tightness 75 (100%) 61 (100%) 14 (100%) – –
Hypopigmentation 17 (22.7%) 12 (19.7%) 5 (35.7%) 0.196 NS
Raynaud’s 73 (97.3%) 59 (96.7%) 14 (100%) 0.492 NS
Digital ischemia 56 (74.6%) 45(73.8%) 11(78.6%) 0.974 NS
Myositis 15 (20%) 11 (18%) 4 (28.6%) 0.374 NS
Arthritis 30 (40%) 27 (44.3%) 3 (21.4%) 0.116 NS
Dysphagia 51 (68%) 40 (65.6%) 11 (78.6%) 0.347 NS
Esophageal reﬂux 29 (38.7%) 22 (36.1%) 7 (50%) 0.344 NS
ILD 40 (53.3%) 29 (47.5%) 11 (78.6%) 0.042 S
PHTN 11(14.7%) 6 (9.8%) 5 (35.7%) 0.014 S
Primary 2 (2.6%) 2 (3.3%) 0 (0%) 0.815 NS
Secondary 9 (12%) 4 (6.6%) 5 (35.7%) 0.009 S
Pericardial eﬀ. 4 (5.3%) 2 (3.3%) 2 (14.3%) 0.098 NS
Proteinuria 5 (6.7%) 2 (3.3%) 3 (21.4%) 0.042 S
Hypertension 6 (8%) 4 (6.6%) 2 (14.3%) 0.310 NS
S: signiﬁcant, NS: non signiﬁcant, ILD: interstitial lung disease, HRCT: high resolution CT, PHTN: pulmonary hypertension and eff.: effusion.
Table 2 Comparison between lcSS and dcSS subtypes as regards the frequency of the ﬁrst presenting symptom.
Presenting manifestation lcSSc (n= 61) dcSSc (n= 14) P-value Sig.
Raynaud’s phenomenon (n,%) 49 (80.3%) 9 (64.3%) 0.347 NS
Arthritis (n,%) 9 (14.8%) 0 (0%) 0.281 NS
Skin tightness (n,%) 2 (3.3%) 5 (35.7%) 0.001 S
Muscle weakness (n,%) 1 (1.6%) 0 (0%) 0.418 NS
n: number, S: signiﬁcant, NS: non signiﬁcant.
Table 1 Comparison between lcSSc and dcSSc subtypes regarding the age of patients, the age of disease onset and disease duration.
lcSSc Mean ± SD dcSSc Mean ± SD P-value Sig.
Age in years (mean ± SD) 34.8 ± 13.3 42.4 ± 15 0.064 NS
Age at disease onset (mean ± SD) 28.7 ± 12.6 35.7 ± 14.5 0.080 NS
Disease duration in years (mean ± SD) 6.1 ± 4.3 7.5 ± 6.2 0.304 NS
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ing the disease course were shown in Table 3, Interstitial lung
disease, secondary pulmonary hypertension and proteinuria
were found to be signiﬁcantly more common among patients
with dcSSc than patients with lcSSc.
On correlation between the disease duration & various clin-
ical parameters in the whole SS patients, we didn’t ﬁnd any sig-
niﬁcant relation apart from the Raynaud’s manifestation that
showed a statistical signiﬁcant correlation with the disease
duration (r= 0.25, P = 0.03).
Manifestations of organs involvement occurred with differ-
ent frequencies between males and females but this difference
wasn’t statistically signiﬁcant (Table 4).
4. Discussion
Systemic sclerosis (SSc) is a connective-tissue disease charac-
terized by an excessive collagen deposition in the dermis and
internal organs, and by vascular hyper-reactivity and oblitera-
tive microvascular phenomena. SSc is responsible for dimin-
ished life expectancy, related to skin extent and visceral
involvement, and is also responsible for tendon, joint, and ves-sel damage, leading to disability, handicap, and impaired
health-related quality of life [8]. It was shown that the extent
of skin involvement, as measured by the Rodnan skin scoring,
regressed in dcSSc with time, although internal organ involve-
ment progressed. Life expectancy has also been conﬁrmed to
be shorter in the diffuse form in several studies, particularly
in women [9].
The aim of this work is to determine the prevalence and dis-
ease characteristics of systemic sclerosis among Egyptian pa-
tients presented to Rheumatology departments in Kasr El
Aini & Bani Swief hospitals. Our study included 75 patients
with systemic sclerosis with male to female ratio of 1:4.3. This
ﬁnding agrees with the results of Tager and Tikly, 1999 (1:4.6)
[10] and Pagalavan and Ong, 2007 (1:3–4) [11], while a higher
ratio was reported in other studies, as in Mukerjee et al.,
2003 (1:5) [12], Alamanos et al., 2005 (1:8.9) [13], Walker
et al., 2007 (1:6.7) [14], and Lo Monaco et al., 2011 (1:9.7) [15].
Coming to the frequency of disease subsets, we found that
the ratio of diffuse: limited was 1:4.3. This ﬁnding goes in line
with many studies which reported that lcSSc is more common
than dcSSc; Alamanos et al., 2005 [13] (1:3), Pagalavan and
Ong, 2007 [11], (1:1.9). Walker et al., 2007 [14] (1:1.6). Hunzel-
mann et al., 2008 [16] (1:1.4), and Lo Monaco et al., 2011 [15]
Table 4 Comparison between males & females as regards the frequency of organ involvement.
Males (%) (n= 14) Females (%) (n= 61) P value Sig.
Skin tightness 14 (100%) 61(100%) – –
Hypopigmentation 3 (21.4%) 14 (23%) 0.902 NS
Raynaud’s 13(92.9%) 60 (98.4%) 0.249 NS
Digital ischemia 11(78.6%) 45(73.8%) 0.974 NS
Myositis 3 (21.4%) 12(19.7%) 0.882 NS
Arthritis 4 (28.6%) 26(42.6%) 0.717 NS
Dysphagia 7 (50%) 44 (72.1%) 0.109 NS
Esophageal reﬂux 3 (21.4%) 26 (42.6%) 0.142 NS
ILD 6(42.9%) 34(55.7%) 0.565 NS
PHTN 0(0%) 11(18%) 0.085 NS
Primary 0 (0%) 2 (3.3%) 0.815 NS
Secondary 0 (0%) 9 (14.7%) 0.281 NS
Pericardial eﬀ. 0 (0%) 4 (6.6%) 0.325 NS
Proteinuria 0 (0%) 5 (8.2%) 0.298 NS
Hypertension 0 (0%) 6 (9.8%) 0.354 NS
Sig.: signiﬁcance. NS: non signiﬁcant.
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fuse systemic sclerosis subtype was more frequent than the lim-
ited one (2.3:1). Also in a recent study of Wang et al., 2012 on
Chinese patients showed 59.7% dcSSc and 40.3% lcSSc [17].
Concerning the frequency of males and females within each
disease subtype, we found that females were signiﬁcantly more
common than males with a male:female ratio of 1:4.6 in LcSSc
and 1:3.7 in dcSSc. Similar result was found in another study;
Hunzelmann et al., 2008 [16], (1:7.2 in lcSSc and 1:3.2 in
dcSSc). In contrast, a higher frequency of males in dcSSc sub-
type was observed in a study by Nguyen et al. 2011 [8].
The commonest initial presenting manifestation among our
patients was found to be Raynaud’s phenomenon in 58/75
(77.3%) patients. This result is similar to that reported by
Pagalavan and Ong, 2007 [11], 70% of their patients presented
with Raynaud’s phenomenon. Tamaki et al. in 1991 [18] found
that Raynaud’s phenomenon was the initial symptom in 59%
of their patients. This frequency difference from our study can
be explained by a higher number of patients (357 in Tamaki
et al. study).
Concerning the frequencies of organ involvement among
our patients during the disease course; arthritis was reported
in 30/75 (40%). Other studies, reported higher frequencies of
articular affection like Pagalavan and Ong in 2007 [11] where
arthralgia/arthritis was observed in 49.2% and Tager and
Tikly., 1999 [10] study, where arthralgia/arthritis was observed
in 68% of their patients. The higher frequencies in these stud-
ies compared to our study may be explained by the difference
in deﬁnition of the reported articular involvement, these two
studies reported all cases of articular involvement whether
arthralgia or arthritis while we reported cases with deﬁnite
arthritis only.
A degree of interstitial lung involvement is present in the
majority of patients with SSc, although severity of lung disease
at presentation and subsequent longitudinal behavior are
highly variable.
Interstitial lung disease (ILD) was reported in 40 (53.3%)
patients, this ﬁnding is similar to the result of Tager and Tikly
in 1999 [10] who found the frequency of pulmonary ﬁbrosis
among patients included in their study to be 56%, while Tama-
ki et al., 1991 [18] reported lower frequency of pulmonary
ﬁbrosis (45%) compared to our results. This may be explainedby the larger sample size in Tamaki et al. study and also by ra-
cial difference. On the other side Pagalavan and Ong in 2007
[11] reported a higher frequency of ILD which was observed
in 70.5% of the 61 SSc patients included in their study who
were collected from different races, where 45.9% of them were
Malays, 39.3% were Chinese and 14.8% were Indians. Phung
et al. in 2009 [19] reported ILD in 17.4% of patients included
in their study. This lower frequency compared to our results
could be explained by their larger sample size (184) and shorter
study duration (2 years). Our study found that interstitial lung
disease was signiﬁcantly more common in the diffuse subtype
(78.6%) than in the limited subtype (47.5%) (P= 0.042). This
ﬁnding met with that ofWalker et al., 2007 [14] and of Hunzel-
mann et al., 2008 [16] (ILD in dcSSc 53.4% and 56.1% and in
lcSSc 34.7% and 20.8%, respectively).
Pulmonary hypertension (PHTN) occurred in 11/75
(14.7%) of our patients, showing a higher frequency within
the diffuse subtype (35.7%), compared to the limited subtype
(9.8%). The difference between both groups was statistically
signiﬁcant (P= 0.014). Primary PHTN (in the absence of
ILD) was found in 2/75 (2.6%) patients and both of them be-
longed to the limited subtype, while secondary PHTN (asso-
ciated with ILD) was found in in 9/75 (12%) of patients. It
was found to be signiﬁcantly more common within dcSSc
subtype (35.7%), compared to lcSSc subtype (6.6%)
(P= 0.009). This result met with that of Tager and Tikly in
1999 [10] who found that PHTN affected 13% of their pa-
tients (11% of them was secondary PHTN and 2% was pri-
mary PHTN). While Phung et al. in 2009 [19], reported a
higher frequency of pulmonary arterial hypertension (24%)
of their patients. This higher frequency can be explained by
Phung et al. study that was directed at diagnosis of PHTN
in SSc, so patients were referred to them because of having
symptoms suggestive of PHTN.
Pericardial effusion was found in 4/75 (5.3%) patients in-
cluded in our study. This goes in line with the results reported
by Tager and Tikly in 1999 [10] who found that serositis was
present in 7% of their patients.
The differences in frequencies of organ involvement be-
tween males and females included in our study were non signif-
icant apart from the ILD and pulmonary HTN that were
reported to be more frequent in females (55.7% & 18%,
Frequency of disease subsets and patterns of organ involvement among Egyptian patients 149respectively) than in males (42.9% & 0%, respectively) but this
difference was not statistically signiﬁcant (P= 0.565 & 0.085).
On the other hand, Nguyen et al. in 2011 [8] found that males
more often exhibited ILD and PHTN than females. This dif-
ference may be caused by racial factors.
Among the Egyptian SS patients; we observed the following:
The Limited subtype is more common than the diffuse. Ray-
naud’s phenomenon is themost common initial diseasemanifes-
tation. Gender does not affect the frequency of organ
involvement in a signiﬁcant way. The Diffuse subtype is more
commonly associated with interstitial lung disease, secondary
pulmonary hypertension and proteinuria than the limited
subtype.
In this study we encountered some limitations as the 75 pa-
tients were not diagnosed nor assessed by the same physicians
(or any of the authors) which adds some deﬁciencies to the pre-
sented results. Also the cardiac involvement was not assessed
due to incomplete documentation.
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